Results

Total Results: 1,528 records

Showing results for "drugs".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer Evidence-based Practice Center Systematic Review Protocol Project Title: Therapies for Clinically Localized Prostate Cancer Initial Publication Date: September 12, 2019 Amendment Date: November 2,…
  2. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … at Point of This Intervention Patients with OA are often prescribed nonsteroidal anti-inflammatory drugs
  3. effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
    March 16, 2017 - How about treatment duration in these drugs? … We have commented on the imprecision for several drugs due to small samples, and have run an adjusted … We had mentioned the limited precision from several drugs. … Public Comment (Cynthia Russo, Janssen Pharmaceuticals, Inc.) … Public Comment (Cynthia Russo, Janssen Pharmaceuticals, Inc.)
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
    March 16, 2017 - How about treatment duration in these drugs? … We have commented on the imprecision for several drugs due to small samples, and have run an adjusted … We had mentioned the limited precision from several drugs. … Public Comment (Cynthia Russo, Janssen Pharmaceuticals, Inc.) … Public Comment (Cynthia Russo, Janssen Pharmaceuticals, Inc.)
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - Conclusions Nonopioid drugs (mainly serotonin-norepinephrine reuptake inhibitor [SNRI] antidepressants … , pregabalin/gabapentin, and nonsteroidal anti-inflammatory drugs [NSAIDs]) resulted in small to moderate … patients with specific types of noncancer chronic pain in the short term, with few differences between drugs … Interventions • Oral pharmacologic agents: nonsteroidal anti-inflammatory drugs, acetaminophen, muscle … events, cardiovascular events, and liver or kidney-related harms for non- steroidal anti-inflammatory drugs
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
    January 30, 2013 - Additionally, combination drug therapy (using multiple drugs with different mechanisms of action) is … www.effectivehealthcare.ahrq.gov Published online: January 30, 2013 4 information regarding the latest drugs … 10, 20, 30, 60, 90 mg Varies Oral Approved Afeditab CR Nifedipine Watson Pharmaceuticals … 30, 60 mg Varies Oral Approved Nifediac Nifedipine Teva Pharmaceuticals 30, 60, 90 mg … 120, 180, 240 mg Varies Oral Off-Label use Diltia Diltiazem Watson Pharmaceuticals 120, 180
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
    August 01, 2020 - for the same drug, while Table 5b summarizes retention findings for XR and daily formulations for drugs … vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs … KQ3: Not reported Fair Rosenthal, 201634 RCT USA Braeburn Pharmaceuticals 177 Age … Medications Timing & Outcome Interventions Results Quality Rating Lofwall, 201835 RCT USA Braeburn Pharmaceuticals
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_disposition-comments.pdf
    April 22, 2013 - Further, adverse effects of antipsychotic drugs have been thoroughly summarized in existing systematic … We have revised the document to emphasize the specific drugs evaluated within classes, paying particular … name amantadine We have revised the key points, results, and SOE table to emphasize the specific drugs … We also reviewed the document to ensure consistency in how drugs were classified. … We acknowledge that some drugs are not readily classified or could be classified in more than one
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-treatments-revised-protocol.pdf
    March 29, 2023 - crisis.10 A recent series of related systematic reviews found that opioids,11 several nonopioid drugs … substances; co-use of kratom or other plant- based substances and opioids All KQs: Co-use of other drugs … • Co-use of other interventions for pain: opioids, nonopioids (e.g. nonsteroidal anti- inflammatory drugs
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
    March 01, 2016 - rates of substance abuse compared to younger women, they may be more vulnerable to the effects of drugs … depression, PTSD, bipolar, schizophrenia), addiction and substance abuse (heroin, cocaine, prescription drugs … , alcohol, smoking, “party” drugs such as MDMA [Ecstasy], Flunitrazepam [Rohypnol], Ketamine), musculoskeletal
  11. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2019.pdf
    January 01, 2019 - AHRQ's Evidence-based Practice Center Division Annual Report 2019: Solving the Puzzle for Evidence-Based Decision Making AHRQ’s Evidence-based Practice Center Divison Annual Report 2019 Solving the Puzzle for Evidence-Based Decision Making e Evidence-based Practice Center Program 2019 Year in Review EPC Missi…
  12. Dia 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/ijzerman_ahrq-webinar-mcda.pdf
    January 01, 2011 - Dia 1 1 Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) Maarten J. IJzerman, PhD Professor and chair, department Health Technology & Services Research m.j.ijzerman@utwente.nl Multiple endpoints in …
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-protocol.pdf
    January 01, 2024 - effective are patient safety practices (PSPs) for identifying and monitoring critical supplies and drugs … and Economic Security (CARES) Act, established in 2020, which required manufacturers of certain drugs
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
    August 01, 2012 - vs. risperidone No significant difference for economic independence (1 RCT) or attitude regarding drugs … the pooled results may not have sufficient power to detect equivalence or noninferiority between drugs … assessed across studies precluded firm conclusions regarding the overall effectiveness of individual drugs … Second-generation versus first- generation antipsychotic drugs for schizophrenia: a meta-analysis.
  15. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … at Point of This Intervention Patients with OA are often prescribed nonsteroidal anti-inflammatory drugs
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-framework-for-conceptualizing-evidence-needs_0.pdf
    December 01, 2017 - Decisions and questions for which health systems seek evidence • Technology (e.g., drugs, devices, products … and use of evidence in health systems focuses on the acquisition of health care technology (i.e., drugs … required evidence.18, 19 In one study, the most common technologies reviewed by HTA programs were drugs … 19% Policy 18% Non-drug, non- device intervention 14% Devices 12% Test, scales, risk factors 8% Drugs … Penn CEP FY2006- 2016 58% Rapid Review (2) 33% Clinical departments 17% CMO 21% Drugs
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - medication (n=2) Sedation (n=4) Constipation (n=4) Headaches (n=3) Nausea/vomiting (n=2) Craving for old drugs … without previous related drug use (including tramadol, Panadol, and Non-Steroidal Anti-Inflammatory Drugs
  18. effectivehealthcare.ahrq.gov/sites/default/files/selection-of-data-sources-chapter-8.pptx
    January 01, 2013 - The NDC is a unique, 10-digit, 3-segment number that is a standard product identifier for human drugs … Claims submitted to insurance companies for payment for drugs are submitted with the NDC number and information … Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly
  19. effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
    January 01, 2013 - exposures of interest are these two treatments, but it is also important to measure exposure to other drugs … such as aspirin or nonsteroidal anti-inflammatory drugs, which could increase the risk of GI bleeds … accurate than the recall of the use of medications (previous use of nonsteroidal anti-inflammatory drugs
  20. effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
    January 01, 2018 - We searched Drugs@FDA for Medical/ Clinical and Statistical review documents containing harm data for … Results are presented in terms of a placebo referent, to rank the drugs based on a common comparator … SGAs Versus SGAs: Comparison of Different Drugs Sixteen (5 long-term) and 37 (13 long-term) studies … Consensus development conference on antipsychotic drugs and obesity and diabetes. … Pediatr Drugs. 2016;18: 319-328. PMID: 27278054. 38. Yoon Y, Wink LK, Pedapati EV, et al.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: